PharVision Advisers’s Xponential Fitness XPOF Stock Holding History

PharVision Advisers’s Portfolio XPOF Stock Details XPOF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-18,395	Closed	-$138K	–	816
2025 Q2	$138K	Buy	+18,395	New	+$152K	0.2%	236

Other funds holding XPOF

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Solel Partners Boston, Massachusetts $468M AUM 2.45% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

PharVision Advisers's XPOF Position: Q3 2025 in Review

PharVision Advisers sold out of Xponential Fitness (XPOF) in Q3 2025, closing a stake of 18,395 shares — an estimated $138K sold.

PharVision Advisers first reported a position in XPOF in Q2 2025 and held it in 1 quarter. The position peaked at $138K in Q2 2025. 125 funds tracked by Wall St. Rank hold XPOF as of Q3 2025.

PharVision Advisers reported no remaining Xponential Fitness position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 18,395 Xponential Fitness shares in Q3 2025, an estimated $138K.
PharVision Advisers first reported a position in Xponential Fitness in Q2 2025 and held it in 1 quarter.
PharVision Advisers's Xponential Fitness position peaked at $138K in Q2 2025.
125 funds tracked by Wall St. Rank held Xponential Fitness as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.